Price (delayed)
$1.64
Market cap
$11.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.67
Enterprise value
$50.09M
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or
There are no recent dividends present for ALIM.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.